Elicio Therapeutics, Inc. (ELTX)

2.565 0.00 (0.00%) USD  |  NASDAQ  |  Sep 02, 16:00
2.565 0.00 (0.00%) After-Hours: 17:53
More

Elicio Therapeutics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for ELTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
August 20, 2026 --
August 18, 2026 --
August 17, 2026 --
August 14, 2026 --
July 02, 2026 --
June 25, 2026 --
June 24, 2026 --
June 18, 2026 --
June 15, 2026 --
June 10, 2026 --
May 12, 2026 --
April 29, 2026 --
April 22, 2026 --
April 15, 2026 --
January 27, 2026 --
January 20, 2026 --
January 12, 2026 --
December 11, 2025 --
November 19, 2025 --
November 14, 2025 --
Date Value
October 16, 2025 --
September 17, 2025 --
August 08, 2025 --
August 07, 2025 --
July 17, 2025 --
June 25, 2025 --
May 16, 2025 --
April 01, 2025 --
March 31, 2025 --
March 24, 2025 --
November 14, 2024 --
October 30, 2024 --
August 23, 2024 --
May 22, 2024 --
May 16, 2024 --
April 23, 2024 --
April 01, 2024 --
October 26, 2023 --
October 24, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Precigen, Inc. Upgrade
Agenus, Inc. Upgrade
Amgen, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
BioCryst Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade